HK1071366A1 - Compounds which inhibit the release of inflammatory cytokines - Google Patents
Compounds which inhibit the release of inflammatory cytokines Download PDFInfo
- Publication number
- HK1071366A1 HK1071366A1 HK05104163A HK05104163A HK1071366A1 HK 1071366 A1 HK1071366 A1 HK 1071366A1 HK 05104163 A HK05104163 A HK 05104163A HK 05104163 A HK05104163 A HK 05104163A HK 1071366 A1 HK1071366 A1 HK 1071366A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fluorophenyl
- ethylamino
- radical
- hydrogen
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32362501P | 2001-09-20 | 2001-09-20 | |
| US60/323,625 | 2001-09-20 | ||
| PCT/US2002/030134 WO2003024970A1 (en) | 2001-09-20 | 2002-09-20 | Compounds which inhibit the release of inflammatory cytokines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1071366A1 true HK1071366A1 (en) | 2005-07-15 |
| HK1071366B HK1071366B (en) | 2006-12-22 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1064362C (zh) | 嘧啶并[5,4－d]嘧啶,含这种化合物的药物,其用途和其制备方法 | |
| CN1257905C (zh) | 抑制炎性细胞因子释放的化合物 | |
| CN1261433C (zh) | 用作神经激肽受体拮抗剂的1,3,8－三氮杂－螺[4.5]癸－4－酮衍生物 | |
| CN1516699A (zh) | 1-[4-(5-氰基吲哚-3-基)丁基]-4-(2-氨甲酰-苯并呋喃-5-基)-哌嗪盐酸盐的多晶型物 | |
| CN1639168A (zh) | 双环吡啶和嘧啶p38激酶抑制剂 | |
| HK1041483A1 (en) | Bicyclic nitrogen heterocycles | |
| HK1052693A1 (zh) | 吡咯並三嗪和嘧啶化合物 | |
| CN1646529A (zh) | 咪唑并稠合化合物 | |
| CN1163495C (zh) | 吡啶化合物、其制备方法和含有它们的药物组合物 | |
| CN1413205A (zh) | 具有抗肿瘤活性的2－(1h－吲哚－3－基)－2－氧代－乙酰胺 | |
| CN1285594C (zh) | 催产素兴奋剂 | |
| CN1275966C (zh) | 吡啶并吡啶并吡咯并 [ 3 , 2 － g ]吡咯并 [ 3 , 4 － e ]吲哚和吡啶并吡咯并[ 2 , 3 － a ]吡咯并 [ 3 , 4 －c ]咔唑化合物 ,其制备方法以及其药物组合物 | |
| CN1510034A (zh) | 新型吲唑化合物,其制备方法及含有它们的药物组合物 | |
| CN1552714A (zh) | 2-取代苯基-5，7-二烃基-3，7-二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其药物用途 | |
| CN1531540A (zh) | 杂环化合物和以其为有效成分的脑机能改善剂 | |
| CN1642600A (zh) | 作为细胞因子介质的1,2－二氢吡唑－3－酮 | |
| HK1071366B (en) | Compounds which inhibit the release of inflammatory cytokines | |
| CN1495163A (zh) | 新的吡咯磺酰胺化合物 | |
| HK1071367A (en) | Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines | |
| HK1071565B (en) | 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines | |
| CN1097010A (zh) | 新的呋喃基噻唑衍生物及其盐 | |
| CN1934112A (zh) | 稠合的杂环化合物及其作为代谢型谷氨酸受体拮抗剂的应用 | |
| CN1942450A (zh) | 取代三唑化合物的制备方法 | |
| HK1052172A1 (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1052172B (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100920 |